{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:43:50Z","timestamp":1794573830496,"version":"4.9.1"},"reference-count":35,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Medicine"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>\n                    Multiple myeloma (MM) is a bone marrow malignancy characterized by plasma cell proliferation. It was aimed to investigate pentraxin 3 (PTX3) levels, oxidative\/antioxidative status, and their correlation in MM. In the study, four groups were established, including newly diagnosed MM (NDMM), MM in remission (Rem-MM), relapsed\/refractory MM (RRMM) patients, and a healthy control group. PTX3 levels were measured using enzyme-linked immunosorbent assay, and the total antioxidant status (TAS) and total oxidant status (TOS) were assessed with an autoanalyzer. The oxidative stress index (OSI) was calculated using the formula: OSI (arbitrary unit)\u2009=\u2009TOS (\u00b5mol H\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    Eq\/L)\/TAS (mmol Trolox Eq\/L)\u2009\u00d7\u2009100. The study involved comparing PTX3, TAS, TOS, and OSI levels among these four groups. PTX3 levels were significantly elevated in NDMM and RRMM groups compared to controls and the Rem-MM group (NDMM vs control; p\u2009&lt;\u20090.001, NDMM vs Rem-MM; p\u2009&lt;\u20090.001, RRMM vs control; p\u2009&lt;\u20090.001, and RRMM vs Rem-MM; p\u2009=\u20090.006). TAS was higher in NDMM and RRMM groups versus controls (p\u2009=\u20090.009 and p\u2009&lt;\u20090.001, respectively), and TOS was higher in rem-MM group versus NDMM and control groups (p\u2009&lt;\u20090.001 and p\u2009=\u20090.016, respectively). OSI was higher in the Rem-MM group than in NDMM and RRMM groups (p\u2009&lt;\u20090.001 and p\u2009=\u20090.009, respectively). Multivariate analysis confirmed associations between MM groups and PTX3 levels. Receiver operating characteristic analysis revealed high specificity (90%) and sensitivity (79%) for PTX3 in NDMM at a &gt;0.56\u2009ng\/mL cut-off value. This study suggests that PTX3 levels may have diagnostic and prognostic potential in MM and its relationship with oxidative stress requires further exploration.\n                  <\/jats:p>","DOI":"10.1177\/10815589241235662","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T22:50:40Z","timestamp":1708383040000},"page":"333-340","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of pentraxin 3 and oxidative status in the prognosis of multiple myeloma"],"prefix":"10.1177","volume":"72","author":[{"given":"Hamdi","family":"O\u011fuzman","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Ka\u00e7maz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Diyarbakir Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"e_1_3_2_3_2","unstructured":"SEER Stat Fact Sheets: Myeloma https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html (2023 accessed 20 January 2024)."},{"key":"e_1_3_2_4_2","unstructured":"GLOBOCAN https:\/\/gco.iarc.fr.html (2020 accessed 20 January 2024)."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2014.03.034"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.07.008"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2005.12.009"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0362-z"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.52.32817"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315302"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.085639"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113738"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092255"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2101105"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236028"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2714"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2005.08.008"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2003.10.014"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1306847"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00712"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512457845"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011780"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.2741\/1667"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2010.04.002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.120144"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad3740"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/10715769900300881"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030455"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8413032"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.1127"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3531"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.01.033"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738872"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9020110"}],"container-title":["Journal of Investigative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10815589241235662","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10815589241235662","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10815589241235662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:40:02Z","timestamp":1777459202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10815589241235662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1177\/10815589241235662"],"URL":"https:\/\/doi.org\/10.1177\/10815589241235662","relation":{},"ISSN":["1081-5589","1708-8267"],"issn-type":[{"value":"1081-5589","type":"print"},{"value":"1708-8267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]}}}